Clinical Trials Directory

Trials / Unknown

UnknownNCT00441636

Treatment Resistant Depression and Obstructive Sleep Apnea, Effect of Continuous Positive Airway Pressure (CPAP)

Treatment Resistant Depression and Obstructive Sleep Apnea: Effect of Treatment With CPAP on Mood, Anxiety and Quality of Life

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Queen's University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine the effect on mood and anxiety symptoms of adding CPAP to the psychiatric treatment of patients with TRD (treatment resistant depression) and associated OSA (obstructive sleep apnea).

Detailed description

Primary objective: What is the effect on mood and anxiety symptoms of adding CPAP to the psychiatric treatment of patients with TRD and associated OSA? Secondary objectives: 1. How common is co-morbid OSA in patients with treatment resistant unipolar depression referred to a tertiary Mood Disorders Clinic? 2. Is there a difference in daytime functioning (severity of depressive and anxiety symptoms, cognitive function, daytime sleepiness) and sleep quality between patients with TRD diagnosed with OSA compared with patients with TRD who have no OSA? 3. What is the association between sleep fragmentation and hypoxemia and the severity of depression in patients with TRD?

Conditions

Interventions

TypeNameDescription
DEVICEcontinuous positive airway pressure (CPAP)CPAP (Respironics: RemStar plus M-series) machines for treatment of obstructive sleep apnea training for participant required by registered sleep technologist

Timeline

Start date
2007-03-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2007-03-01
Last updated
2018-04-30

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00441636. Inclusion in this directory is not an endorsement.